A case-control study on risk factors associated with death in pregnant women with severe pandemic H1N1 infection

Acute Infectious Disease Prevention and Control, Anhui Provincial CDC, Hefei, Anhui, China.
BMJ Open (Impact Factor: 2.27). 07/2012; 2(4). DOI: 10.1136/bmjopen-2012-000827
Source: PubMed


To describe the risk factors associated with death in pregnant women with severe pandemic H1N1 infection.
Case-control study.
Anhui, China.
A total of 46 pregnant women with severe pandemic H1N1 infection were studied during June 2009-April 2011. PRIMARY AND SECONDARY OUTCOME MEASURES: All the cases were confirmed by the clinicians and epidemiologists together based on the positive laboratory result.
Of the seven pregnant women who died of the pandemic H1N1 infection, five (70%) cases were in their third trimester. Twenty-nine (63%) cases from the surviving group were admitted to hospital within 3 days after the onset of symptoms, while only one (2%) case from the death group took the earliest admission 2 days after the onset. There was a significant difference on how soon to be admitted between the death and the surviving groups (OR 0.09, 95% CI 0.01 to 0.68). The median time of administrating corticosteroids was 5 days after the onset in the death group and 3 days in the surviving group showing no significant difference between them (p=0.056).
For the pregnant women with severe p(H1N1) infection, the risk factors associated with death were as follows: the delay of antiviral treatment and being in the third trimester. The corticosteroids therapy appeared to have no effects on preventing the cases from death.

8 Reads
  • American Journal of Obstetrics and Gynecology 04/1960; 78(2):1172-5. DOI:10.1097/00006254-196004000-00013 · 4.70 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Planning for a future influenza pandemic should include considerations specific to pregnant women. First, pregnant women are at increased risk for influenza-associated illness and death. The effects on the fetus of maternal influenza infection, associated fever, and agents used for prophylaxis and treatment should be taken into account. Pregnant women might be reluctant to comply with public health recommendations during a pandemic because of concerns regarding effects of vaccines or medications on the fetus. Guidelines regarding nonpharmaceutical interventions (e.g., voluntary quarantine) also might present special challenges because of conflicting recommendations about routine prenatal care and delivery. Finally, healthcare facilities need to develop plans to minimize exposure of pregnant women to ill persons, while ensuring that women receive necessary care.
    Emerging infectious diseases 02/2008; 14(1):95-100. DOI:10.3201/eid1401.070667 · 6.75 Impact Factor
  • Source
    New England Journal of Medicine 06/2010; 362(24):2241-3. DOI:10.1056/NEJMp1003462 · 55.87 Impact Factor
Show more


8 Reads
Available from